Abstract 1893: Activating NRAS mutations are associated with FLT3-independent resistance to the clinically active FLT3 inhibitor AC220 in vitro.

Elisabeth A. Lasater, Catherine C. Smith, Neil P. Shah. Abstract 1893: Activating NRAS mutations are associated with FLT3-independent resistance to the clinically active FLT3 inhibitor AC220 in vitro. Experimental and Molecular Therapeutics. 2012 Apr 15; 1893-1893.

2012
https://researcherprofiles.org/profile/79293935

Elisabeth A. Lasater, Catherine C. Smith, Neil P. Shah